Select Medical Holdings Corporation

NYSE:SEM 주식 보고서

시가총액: US$4.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Select Medical Holdings 관리

관리 기준 확인 1/4

Select Medical Holdings' CEO는 David Chernow, Jan2014 에 임명되었습니다 의 임기는 10.42 년입니다. 총 연간 보상은 $ 10.71M, 9.3% 로 구성됩니다. 9.3% 급여 및 90.7% 보너스(회사 주식 및 옵션 포함). 는 $ 39.95M 가치에 해당하는 회사 주식의 0.9% 직접 소유합니다. 39.95M. 경영진과 이사회의 평균 재임 기간은 각각 1.3 년과 14.8 년입니다.

주요 정보

David Chernow

최고 경영자

US$10.7m

총 보상

CEO 급여 비율9.3%
CEO 임기10.7yrs
CEO 소유권0.8%
경영진 평균 재임 기간1.5yrs
이사회 평균 재임 기간10.1yrs

최근 관리 업데이트

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Recent updates

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Aug 05
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

Jul 19
Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Jul 01
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13
Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26
There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05
Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18
Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Jan 15
We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Dec 31
Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Nov 06
Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16
Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07
Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14
Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29
At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05
Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17
Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20
The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01
Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Select Medical declares $0.125 dividend

Nov 03

These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Nov 01
These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Sep 16
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Adding To Position For Further Upside Capture

Sep 14

CEO 보상 분석

David Chernow 의 보수는 Select Medical Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$259m

Mar 31 2024n/an/a

US$260m

Dec 31 2023US$11mUS$995k

US$235m

Sep 30 2023n/an/a

US$217m

Jun 30 2023n/an/a

US$196m

Mar 31 2023n/an/a

US$174m

Dec 31 2022US$9mUS$995k

US$153m

Sep 30 2022n/an/a

US$175m

Jun 30 2022n/an/a

US$223m

Mar 31 2022n/an/a

US$329m

Dec 31 2021US$12mUS$995k

US$389m

Sep 30 2021n/an/a

US$415m

Jun 30 2021n/an/a

US$415m

Mar 31 2021n/an/a

US$306m

Dec 31 2020US$8mUS$995k

US$250m

Sep 30 2020n/an/a

US$206m

Jun 30 2020n/an/a

US$162m

Mar 31 2020n/an/a

US$155m

Dec 31 2019US$8mUS$995k

US$143m

Sep 30 2019n/an/a

US$136m

Jun 30 2019n/an/a

US$138m

Mar 31 2019n/an/a

US$140m

Dec 31 2018US$8mUS$995k

US$133m

Sep 30 2018n/an/a

US$207m

Jun 30 2018n/an/a

US$193m

Mar 31 2018n/an/a

US$189m

Dec 31 2017US$7mUS$984k

US$171m

보상 대 시장: David 의 총 보상 ($USD 10.71M )은 US 시장( $USD 6.74M ).

보상과 수익: David 의 보상은 지난 1년 동안 20% 이상 증가했습니다.


CEO

David Chernow (67 yo)

10.7yrs

테뉴어

US$10,706,265

보상

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...


리더십 팀

이름위치테뉴어보상소유권
Robert Ortenzio
Co-Founder & Executive Chairman19.6yrsUS$10.77m6.89%
$ 310.4m
David Chernow
Chief Executive Officer10.7yrsUS$10.71m0.78%
$ 35.0m
Rocco Ortenzio
Co-Founder & Chairman Emeritus27.6yrsUS$7.08m6.04%
$ 272.5m
Michael Malatesta
Executive VP & CFOless than a yearUS$1.53m0.15%
$ 7.0m
Michael Tarvin
Senior Executive VP27.6yrsUS$4.44m0.36%
$ 16.1m
Martin Jackson
Senior Executive Vice President of Strategic Finance & Operationsless than a yearUS$6.47m1.01%
$ 45.6m
John Saich
Co-Presidentless than a year데이터 없음0.53%
$ 24.1m
Thomas Mullin
Co-Presidentless than a year데이터 없음0.28%
$ 12.5m
Christopher Weigl
Senior VP1.5yrs데이터 없음0.031%
$ 1.4m
Brian Rusignuolo
Executive VP & Chief Information Officer3.7yrs데이터 없음0.26%
$ 11.7m
Robert Breighner
Senior Vice President of Compliance & Auditno data데이터 없음0.029%
$ 1.3m
Shelly Eckenroth
Senior VP & Chief Communicationsless than a year데이터 없음데이터 없음

1.5yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: SEM 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Robert Ortenzio
Co-Founder & Executive Chairman19.6yrsUS$10.77m6.89%
$ 310.4m
Rocco Ortenzio
Co-Founder & Chairman Emeritusless than a yearUS$7.08m6.04%
$ 272.5m
Russell Carson
Independent Lead Director19.6yrsUS$384.40k0.84%
$ 38.0m
Thomas Scully
Independent Director20.6yrsUS$383.40k0.069%
$ 3.1m
Daniel Thomas
Independent Director5.2yrsUS$405.80k0.051%
$ 2.3m
William Frist
Independent Director14.3yrsUS$407.83k0.22%
$ 9.9m
Marilyn Tavenner
Independent Director5.8yrsUS$394.40k0.042%
$ 1.9m
James Ely
Independent Director15.8yrsUS$414.83k0.11%
$ 5.1m
Katherine Davisson
Independent Director3.4yrsUS$409.80k0.035%
$ 1.6m
Parvinderjit Khanuja
Independent Director2.8yrsUS$407.83k0.033%
$ 1.5m

10.1yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: SEM 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 14.8 년).